| FOHTX | FOITX | FOHTX / FOITX | |
| Total Expense Ratio | 0.78 | 1.20 | 65% |
| Annual Report Gross Expense Ratio | 0.79 | 1.20 | 66% |
| Fund Existence | 41 years | 31 years | - |
| Gain YTD | 1.373 | 1.493 | 92% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 2500 | 1000 | 250% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 426M | 899M | 47% |
| Annual Yield % from dividends | 3.43 | 2.90 | 118% |
| Returns for 1 year | 6.50 | 7.13 | 91% |
| Returns for 3 years | 8.28 | 9.96 | 83% |
| Returns for 5 years | 1.67 | -3.74 | -45% |
| Returns for 10 years | 11.86 | 0.36 | 3,280% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SBTU | 1.98 | 0.18 | +9.70% |
| T-REX 2X Long SBET Daily Target ETF | |||
| TPIF | 37.37 | 0.96 | +2.64% |
| Timothy Plan International ETF | |||
| FTXH | 36.09 | 0.76 | +2.17% |
| First Trust Nasdaq Pharmaceuticals ETF | |||
| ILCV | 101.22 | 1.21 | +1.21% |
| iShares Morningstar Value ETF | |||
| RDYY | 20.80 | 0.21 | +1.04% |
| YieldMax RDDT Option Income Strategy ETF | |||